Berachain emerges as a DeFi leader during the recent crypto bull run, securing unicorn status with a staggering $1.5 billion valuation.

An insightful exploration into China's rapid development of automotive safety, focusing on functional safety and SOTIF, highlighting the country’s regulatory advancements and their implications for the global automotive market.

Seegene Inc. partners with Springer Nature to award innovative research grants focused on pioneering diagnostic solutions for infectious diseases, reinforcing the global commitment towards a disease-free future.

Minesto AB, renowned for its innovative marine energy solutions, has officially registered its Rights Issue Prospectus with the Swedish authorities. This move signals a substantial step forward in bolstering green energy investments and aligning with global carbon footprint reduction goals.

Amidst a landscape of technological resilience, the rugged servers market is poised for a significant upsurge with an anticipated growth of USD 751.25 million by 2027, propelled by military and data center demands for robust, climate-optimized storage solutions.

Nvidia's GPU Technology Conference (GTC) unveils groundbreaking advancements in AI chips and strategic plans, cementing its position as a leader in the AI revolution. The event, highly anticipated by Wall Street, is expected to showcase the powerful B100 chip and discuss artificial intelligence's boundless future.

OKX, a prominent Web3 technology firm, has unveiled innovative wallet features including mass account creation and advanced multisending options, significantly simplifying the airdrop participation process for cryptocurrency enthusiasts globally.

CCELL® revolutionizes the European cannabis market by showcasing its latest vaporization technologies at Spannabis, Europe's premier cannabis fair.

Luxshare-TECH takes center stage at OFC 2024 with its innovative optical modules designed for AI servers, showcasing high-speed, low-latency solutions that promise to revolutionize the AI industry. Attendees will experience cutting-edge technology that sets new standards in data transfer efficiency, supporting the future of artificial intelligence and data center operations.

Selvita S.A. announces a significant strategic expansion into therapeutic antibody discovery, showcasing an ambitious move to enhance their biologic drug discovery and development capabilities. The initiative, indicative of Selvita's commitment to innovation, positions the company as a leader in biologic research and caters to the growing needs of the pharmaceutical industry.